Aliya-Jasmine Sovani brings back sex-ed class
Sovani and Flare.com host Google Hangout with young Canadian women to kick start conversation about sex and contraception
TORONTO, June 10, 2014 /CNW/ - When was last time you had a Sex Ed class? Chances are, it's been a while. On June 11th, television personality Aliya-Jasmine Sovani – no stranger to a taboo topic or two – will take part in a campaign designed to start a conversation with young women about a better way to take control of their bodies and focus on achieving their goals without the stress of an unplanned pregnancy. Sovani is tackling this hot topic by hosting a 'Sex Ed Refresh' Google Hangout with social media followers followed by a 'Sex Ed 2.0' class event for media and influencers. Ms. Sovani is looking to empower women to stay on track with their career and life goals without the worry of unintended pregnancy.
"When's the last time you took a Sex Ed class? Probably in your high school gym!" said Aliya-Jasmine Sovani. "I love having candid conversations with the young women who watch me on TV. When it comes to our bodies it is empowering knowing all of the options available to us. My career has been my focus since I was a teenager, so I understand wanting to concentrate on those life goals. Now there's an option that makes it even easier for a woman to really focus on her career without the worry of getting pregnant before she's ready to plan for a family."
To help young women understand all the contraceptive options available to them, women's health expert Dr. Natashia Grell will answer any and all questions about sexual health and birth control.
The Flare.com-hosted Google Hangout, which will take place at 6:00 p.m. on Wednesday, June 11, will feature a frank discussion on topics like sex, contraception, unplanned pregnancy and achieving your career goals and while allowing Canadian women to ask their questions to Sovani and Dr. Grell. To join the conversation tweet @aliyajasmine using #FlareSexEd and visit http://www.flare.com/beauty/health/aliya-jasmine-sovani-sex-education to watch.
After the Hangout, Sovani is teaming up with New York cool kid, DJ and founder of the Beautified app, Hannah Bronfman, at a media event for a Beyonce-inspired dance class followed by some girl talk with women's health experts – Dr. Grell MD as well as sexpert Dr. Jess O'Reilly PhD.
Who: Aliya-Jasmine Sovani, Dr. Natashia Grell MD and Dr. Jess O'Reilly
When: June 11 @ 6 pm
Join: Tweet @aliyajasmine using #FlareSexEd
Media Event: Sex Ed 2.0
Who: Aliya-Jasmine Sovani, Dr. Natashia Grell, Dr. Jess O'Reilly and Hannah Bronfman
When: June 11 @ 7 pm
Where: The Extension Room, 30 Eastern Avenue, Toronto
Who: Aliya-Jasmine Sovani and Dr. Natashia Grell MD
When: June 11 – all day
Where: Toronto for television; print, online or radio interviews available throughout Canada
Contact: Shelley Thomas, Narrative PR, 416-357-7829, Shelley.Thomas@narrative.ca
About Bayer in Canada
Bayer Inc. is a Canadian subsidiary of Bayer AG and the corporate headquarters for the Canadian operations. Founded in 1863, Bayer AG is an international research-based group with core businesses in healthcare, crop science and innovative materials committed to creating a better life for all through science.
In Canada, Bayer operates its healthcare business – Pharmaceuticals, Consumer Care, Diabetes Care, Animal Health and Radiology & Interventional – from its headquarters in Toronto, ON, and Bayer CropScience Inc. operates out of its head office in Calgary, AB. Together with its material science business, Bayer improves the quality of life for Canadians through products that fight disease, protect crops and animals, and provide high-performance materials for numerous daily life uses.
With more than 1,300 employees across the country, in 2013, Bayer had sales of $1.6 billion and invested $61 million in research and development in Canada. Globally, Bayer AG had sales of €40.2 billion and invested €3.2 billion in research and development.
For more information about Bayer, please visit www.bayer.ca.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
SOURCE Bayer Inc.For further information: Shelley Thomas, Narrative PR, 416-357-7829, Shelley.Thomas@narrative.ca; Emily Hanft, Bayer Inc., 416-240-5466, email@example.com